Hexarelin
Research PhaseHexarelin (Examorelin)
- Category
- Growth Hormone
- Aliases
- Examorelin, HEX
- Administration
- Subcutaneous injection, Intranasal (studied)
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
Increased appetite and a brief flushing sensation are commonly reported within the first days of use, consistent with its strong ghrelin receptor activity.
- 2
3–4 Weeks
Some users report early signs of improved recovery, though desensitization (a reduced response over time) is also commonly discussed within this window.
- 3
5–7 Weeks
Many users report cycling off around this point specifically to manage desensitization and cortisol-related effects.
- 4
8–10 Weeks
Continued or cyclical use is common; sustained daily use beyond this point is less frequently discussed given desensitization concerns.
- 5
11–15 Weeks
Available evidence does not describe outcomes for continuous use at this duration.
- 6
16–20 Weeks
Available evidence does not describe outcomes for continuous use at this duration.
- 7
21–24 Weeks
Available evidence does not describe outcomes for continuous use at this duration.
⚠️ Research context only. This is not medical advice and results are not guaranteed.